Oncternal Therapeutics Inc logo

Oncternal Therapeutics Inc Share Price Today (NASDAQ: ONCT)

Oncternal Therapeutics Inc share price is $0 & ₹0.00 as on 1 Dec 2024 IST

-0.53

(-100%)

Market is closed - opens 7 PM, 10 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 2 Dec 2024

View live Oncternal Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Oncternal Therapeutics Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Oncternal Therapeutics Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Oncternal Therapeutics Inc (ONCT) Key Statistics

in dollars & INR

Previous Close
$0.5266
Open
$0.7
Market Capitalization
$3.3M
Today's Volume
$673.1K
Revenue TTM
$2.2M
Earnings Per Share (EPS)
$-11.39
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-149.86%

How to invest in Oncternal Therapeutics Inc Stock (ONCT) from India?

It is very easy for Indian residents to invest directly in Oncternal Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oncternal Therapeutics Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oncternal Therapeutics Inc or ONCT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oncternal Therapeutics Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oncternal Therapeutics Inc shares which would translate to null fractional shares of Oncternal Therapeutics Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Oncternal Therapeutics Inc, in just a few clicks!

Global Institutional Holdings in Oncternal Therapeutics Inc

  • Vanguard Group Inc

    4.83%

  • Millennium Management LLC

    3.48%

  • BlackRock Inc

    1.33%

  • Morgan Stanley - Brokerage Accounts

    1.02%

  • Dimensional Fund Advisors, Inc.

    0.89%

  • Geode Capital Management, LLC

    0.87%

Analyst Recommendation on Oncternal Therapeutics Inc

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Oncternal Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Oncternal Therapeutics Inc

Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins, which is in Phase 1/2 clinical trial. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T), which is in Phase 1/2 clinical trial for the treatment of hematologic malignancies and solid tumors, as well as targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate in preclinical development for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. The company has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. is headquartered in San Diego, California.
Organization
Oncternal Therapeutics Inc
Employees
27
CEO
Dr. James B. Breitmeyer M.D., Ph.D.
Industry
Biotechnology

Important FAQs about investing in ONCT Stock from India :

Can Indians buy Oncternal Therapeutics Inc shares?

Yes, Indians can invest in the Oncternal Therapeutics Inc (ONCT) from India.

With INDmoney, you can buy Oncternal Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Oncternal Therapeutics Inc at zero transaction cost.

How can I buy Oncternal Therapeutics Inc shares from India?

It is very easy to buy Oncternal Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oncternal Therapeutics Inc (ONCT) be purchased?

Yes, you can buy fractional shares of Oncternal Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Oncternal Therapeutics Inc stocks?

To start investing in Oncternal Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Oncternal Therapeutics Inc?

Today's market capitalisation of Oncternal Therapeutics Inc ONCT is 3.3M

Who is the Chief Executive Officer (CEO) of Oncternal Therapeutics Inc ?

Dr. James B. Breitmeyer M.D., Ph.D. is the current Chief Executive Officer (CEO) of Oncternal Therapeutics Inc.